Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk

被引：11
|
作者：
Arnott, Clare [1 ,2 ,3 ]
Fletcher, Robert A. [1 ]
Neal, Bruce [1 ,4 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Level 5,1 King St, Sydney, NSW 2042, Australia
[2] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[4] Imperial Coll London, Dept Epidemiol & Biostat, London, England
来源：
HEART FAILURE CLINICS | 2022年 / 18卷 / 04期
关键词：
SGLT2; inhibitors; Meta-analysis; Amputation; Fracture; TYPE-2; CANAGLIFLOZIN;
D O I：
10.1016/j.hfc.2022.03.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：645 / 654
页数：10
相关论文
共 50 条
  • [41] Sodium-glucose cotransporter 2 inhibitors and bullous pemphigoid risk in US and global population: real world evidences
    Chang, Hui-Chin
    Chiu, Tsu-Man
    Jhang, Yi-Sheng
    Chen, Shiu-Jau
    Su, Yu-Jung
    Wu, Meng-Che
    Gau, Shuo-Yan
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [42] Effects of sodium-glucose cotransporter 2 inhibitors on risk of venous thromboembolism in patients with type 2 diabetes: A systematic review and meta-analysis
    Wang, Aihua
    Yang, Keming
    Wang, Tiansheng
    Zhang, Ning
    Tang, Huilin
    Feng, Xin
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (01)
  • [43] Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Across the Spectrum of Hypertension
    Sanidas, Elias A.
    Papadopoulos, Dimitrios P.
    Hatziagelaki, Erifili
    Grassos, Charalampos
    Velliou, Maria
    Barbetseas, John
    AMERICAN JOURNAL OF HYPERTENSION, 2020, 33 (03) : 207 - 213
  • [44] The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 Diabetes
    Steen, Oren
    Goldenberg, Ronald M.
    CANADIAN JOURNAL OF DIABETES, 2017, 41 (05) : 517 - 523
  • [45] Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure
    Shah, Kevin S.
    Fang, James C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 109 - 120
  • [46] Sodium-glucose cotransporter 2 inhibitors' mechanisms of action in heart failure
    Rotkvic, Petra Grubic
    Berkovic, Maja Cigrovski
    Bulj, Nikola
    Rotkvic, Luka
    Celap, Ivana
    WORLD JOURNAL OF DIABETES, 2020, 11 (07) : 269 - 279
  • [47] Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review
    Shah, Chintan, V
    Sparks, Matthew A.
    Lee, Chien-Te
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (05) : 648 - 658
  • [48] Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis
    Dawwas, Ghadeer K.
    Flory, James H.
    Hennessy, Sean
    Leonard, Charles E.
    Lewis, James D.
    DIABETES CARE, 2022, 45 (04) : 919 - 927
  • [49] CARDIOPROTECTIVE MECHANISMS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS
    Mkrtumyan, Ashot M.
    Markova, Tatyana N.
    Mishchenko, Nadezhda K.
    DIABETES MELLITUS, 2021, 24 (03): : 291 - 299
  • [50] Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes
    Steinberg, Helmut O.
    POSTGRADUATE MEDICINE, 2016, 128 (04) : 398 - 408
12345